SYNERGY PHARMACEUTICALS (SGYP) Covered Calls

SYNERGY PHARMACEUTICALS covered calls Synergy Pharmaceuticals, Inc. is a development stage biopharmaceutical company, whose main focus is on the development of drugs to treat GI disorders and diseases.

You can sell covered calls on SYNERGY PHARMACEUTICALS to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SGYP (prices last updated Fri 4:16 PM ET):

SYNERGY PHARMACEUTICALS (SGYP) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
1.63 -0.05 1.61 1.65 1.8M - 0.4B
Covered Calls For SYNERGY PHARMACEUTICALS (SGYP)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 1.5 0.15 1.50 0.0% 0.0%
Jul 20 1.5 0.25 1.40 7.1% 45.5%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Synergy Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of drugs to treat gastrointestinal disorders and diseases. Its lead product candidate includes plecanatide a phase 3 guanylate cyclase C, or GC-C, receptor agonist, designed to treat GI disorders, primarily chronic idiopathic constipation, or CIC, and constipation-predominant irritable bowel syndrome, or IBS-C. CIC and IBS-C are functional gastrointestinal disorders that afflict millions of individuals worldwide. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.